HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gonadal function in adolescent patients submitted to chemotherapy during childhood or during the pubertal period.

AbstractSTUDY OBJECTIVE:
To determine the presence of impaired gonadal function in adolescent patients submitted to chemotherapy during childhood or during the pubertal period.
DESIGN:
A case series study of 28 patients aged 12 to 19 years with menarche at least 2 years before the study.
SETTING:
Tertiary care public hospital.
PARTICIPANTS:
Group I: 14 adolescents previously submitted to chemotherapy during the prepubertal or peripubertal period and with remission of oncologic disease for at least 2 years; Group II: 14 normal adolescents with no previous oncologic disease and with regular menstrual cycles.
INTERVENTIONS AND MAIN OUTCOME MEASURES:
Pubertal development, menstrual cycles and serum levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were determined during the early follicular phase.
RESULTS:
There were no differences between the two groups in terms of age at appearance of secondary sexual characteristics or age at menarche. Menstrual irregularity was detected in 7 of the 14 patients in Group I, all 8 of whom presented oligomenorrhea. There were no differences in LH levels between the two groups (P = 0.55), although mean FSH levels were higher in Group I than in Group II (6.71 +/- 2.99 mIU/ml vs. 3.83 +/- 2.01 mIU/ml, P = 0.01).
CONCLUSION:
Although girls submitted to chemotherapy during the prepubertal or peripubertal period presented normal sexual development, the incidence of oligomenorrhea was higher than expected for their age, and FSH levels, although within normal limits, were higher than those seen in normally cycling girls.
AuthorsAna Carolina J S Rosa e Silva, Julio Cesar Rosa e Silva, Rosana M Reis, Luís G Tone, Marcos F Silva de Sá, Rui A Ferriani
JournalJournal of pediatric and adolescent gynecology (J Pediatr Adolesc Gynecol) Vol. 20 Issue 2 Pg. 89-91 (Apr 2007) ISSN: 1083-3188 [Print] United States
PMID17418392 (Publication Type: Historical Article, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Follicle Stimulating Hormone
Topics
  • Adolescent
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Child
  • Female
  • Follicle Stimulating Hormone (blood)
  • Hematologic Neoplasms (drug therapy)
  • History, 16th Century
  • Humans
  • Incidence
  • Oligomenorrhea (epidemiology)
  • Ovary (drug effects)
  • Puberty (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: